Acorah Software Products - Accounts Production16.3.350falsetrue30 June 20231 July 2022falsetrueNo description of principal activity1 July 202330 June 202430 June 202411627685Mr Zafirahmad Pateliso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure116276852023-06-30116276852024-06-30116276852023-07-012024-06-3011627685frs-bus:PrivateLimitedCompanyLtd2023-07-012024-06-3011627685frs-bus:FilletedAccounts2023-07-012024-06-3011627685frs-bus:Micro-entities2023-07-012024-06-3011627685frs-bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3011627685frs-bus:Director12023-07-012024-06-30116276852022-06-30116276852023-06-30116276852022-07-012023-06-30
Registered number: 11627685
Alpha Pharmachem Ltd.
Financial Statements
For The Year Ended 30 June 2024
Patel & Co. Accountants
362 Derby Street
Bolton
BL3 6LS
Alpha Pharmachem Ltd.
Balance Sheet
As At 30 June 2024
Balance Sheet
Registered number: 11627685
2024
2023
£
£
Fixed assets
1,517
1,517
Current assets
208
1,461
NET CURRENT ASSETS
208
1,461
TOTAL ASSETS LESS CURRENT LIABILITIES
1,725
2,978
NET ASSETS
1,725
2,978
CAPITAL AND RESERVES
1,725
2,978
Notes
1.General Information
Alpha Pharmachem Ltd. is a private company, limited by shares, incorporated in England & Wales, registered number 11627685. The registered office is 206 Morris Green Lane, Bolton, BL3 3LB.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
--
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.